APPENDIX A |
|
|
|
|
Proposed Amendments to form CDC 54.1 (Malaria Case Surveillance Report) |
|
|
|
|
|
|
|
|
|
***Changes are in Bold font |
|
|
|
|
|
|
|
|
|
Current Form (Field Names) |
Current Value Set |
Proposed Form (Field Names) |
Proposed Value Set |
Justification |
DASH No. |
|
CSID No. |
|
DASH changed to CSID (CDC Specimen Identifier ) to conform to the new changes in laboratory specimen identification system in place |
County |
|
County |
|
Field placement has been moved underneath "State/territory reporting this case" |
Age/ (yrs)(mos) |
|
Age/ yrs. mos. wks. days (circle units) |
|
Change to account for various reporting age units |
Lab results |
Smear positive, smear negative, No smear taken |
Positive lab test result (check all that apply) |
Smear, PCR, RDT, No test done/unknown |
Change to capture PCR and RDT positive test results |
Species (check all that apply) |
Vivax, Falciparum, Malariae, Ovale, Not determined |
Species (check all that apply) |
Vivax, Falciparum, Malariae, Ovale, Not determined, Other (specify) |
Change to capture other plasmodium species |
NEW FIELD |
|
Parasitemia (%) |
|
Added to capture parasetemia data if available |
Patient admitted to hospital |
Yes, No |
Patient admitted to hospital |
Yes, No, Unknown |
Added unknown as a possible value to collect more accurate data |
Specimen being sent to CDC |
Yes, No |
Specimen being sent to CDC |
Yes, No, Unknown |
Added unknown as a possible value to collect more accurate data |
Has patient traveled or lived outside the US during the past 4 year? |
Yes, No |
Has patient traveled or lived outside the US during the past 2 year? |
Yes, No |
Change to 2 years sufficiently captures travel history |
Duration of stay in foreign country (days) |
|
Duration in country/ yrs. mos. wks. days (circle units) |
|
Reworded Change to account for various reporting duration/time units |
Did patient reside in US prior to most recent travel? |
Yes, for ≥12 months, Yes, for <12 months, No (specify country), Unknown |
Did patient reside in US prior to most recent travel? |
Yes, No (specify country), Unknown |
Simplified value set to capture the same data; Added unknown as a possible value to collect accurate data |
Principal reason for travel from/to US for most recent trip |
Tourism, Military, Business, Peace Corps, Visiting friends/relatives, Airline/ship crew, Missionary or dependent, Refugee/immigrant, Student/teacher, Other |
Principal reason for travel from/to US for most recent trip |
Tourism, Military, Business, Peace Corps, Visiting friends/relatives, Airline/ship crew, Missionary or dependent, Refugee/immigrant, Student/teacher, Other, Unknown |
Added unknown as a possible value to collect more accurate data |
Was malaria chemoprophylaxis taken |
Yes, No |
Was malaria chemoprophylaxis taken |
Yes, No, Unknown |
Added unknown as a possible value to collect more accurate data |
If yes, which drugs were taken |
Chloroquine, Mefloquine, Doxycycline, Primaquine, Malarone, Other |
If yes, which drugs were taken |
Chloroquine, Mefloquine, Doxycycline, Primaquine, Atovaquone/proguanil, Other, Unknown |
Used chemical name of Malarone; Added unknown as a possible value to collect more accurate data |
Were all pills taken as prescribed |
Yes missed no doses, No missed one to a few doses, No missed more than a few but <half of the doses, No missed doses but not sure how many, Don't know |
Were all pills taken as prescribed |
Yes missed no doses, No missed doses, Unknown |
Simplified value set to capture the same data |
If doses were missed, what was the reason |
Forgot, Didn’t think needed, Had a side affect (specify), Was advised by others to stop, Prematurely stopped taking once home, Other (specify) |
If doses were missed, what was the reason |
Forgot, Didn’t think needed, Had a side affect (specify), Was advised by others to stop, Prematurely stopped taking once home, Other (specify), Unknown |
Added unknown as a possible value to collect more accurate data |
History of malaria in last 12 months (prior to this report) |
Yes, No |
History of malaria in last 12 months (prior to this report) |
Yes, No, Unknown |
Added unknown as a possible value to collect more accurate data |
If yes, species (check all that apply) |
Vivax, Falciparum, Malariae, Ovale, Not determined |
If yes, species (check all that apply) |
Vivax, Falciparum, Malariae, Ovale, Not determined, Other (specify) |
Change to capture other plasmodium species |
Blood transfusion/organ transplant within last 12 months |
Yes, No |
Blood transfusion/organ transplant within last 12 months |
Yes, No, Unknown |
Added unknown as a possible value to collect more accurate data |
Clinical Complications |
Cerebral malaria, Renal Failure, ARDS, Anemia (Hb<11, Hct<33), None, Other |
Clinical Complications |
Cerebral malaria, Renal Failure, ARDS, Severe anemia (Hb<7), None, Other |
Changed Anemia value to better identify associated clinical complications |
Was illness fatal |
Yes, No |
Was illness fatal |
Yes, No, Unknown |
Added unknown as a possible value to collect more accurate data |
Therapy for this attack (check all that apply) |
Chloroquine, Tetracycline/Doxycycline, Mefloquine, Exchange transfusion, Unknown, Primaquine, Quinine/quinidine, Pyrimethamine-sulfadoxine, Malarone, Other (specify) |
Therapy for this attack (check all that apply) |
Chloroquine, Tetracycline, Doxycycline, Mefloquine, Exchange transfusion, Unknown, Primaquine, Quinine, Quinidine, Clindamyacin, Atovaquone/proguanil, Artesunate, Other (specify) |
Used chemical name of Malarone; Updated value set to capture drugs available for treatment |
Date |
|
Date Submitted |
|
Change to clarify date description |